Amneal Pharmaceuticals of New York LLC announced the approval of its abbreviated new drug application (ANDA) for hydrocodone bitartrate and acetaminop...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Amneal Pharmaceuticals LLC has been granted approval for the ANDA040746 filing, securing the generic market for FDA-approved, oral-conditioned hydroco...
On August 23, 2006, Dr. Reddy's Laboratories received FDA approval for ANDA077787, marking a key move to expand its generic drug portfolio. The approv...
Gravi Pharma announced that its generic drug has received FDA approval, a development expected to facilitate market entry and potentially generate rev...
Organon LLC reported the U.S. Food and Drug Administration's approval of its subcutaneous implantable contraceptive, NEXPLANON, marking a pivotal expa...
Sandoz announced late Tuesday that its ANDA submission for the New Drug Application, ANDA075428, received FDA approval on January 24. This clearance i...
Strides Pharma Intl announced the approval of a generic drug application in January 2006. This early-stage development marked a significant step for t...
Strides Pharma International announced today that the U.S. Food and Drug Administration approved its Abbreviated New Drug Application (ANDA) for the s...
# FDA Approves SOLA Pharmaceuticals' Generic Cabergoline The FDA has approved SOLA Pharmaceuticals' abbreviated new drug application for generic cabe...
SUN PHARM INDUSTRIES received final FDA approval on December 21 for ANDA077124, signaling a potential generic opportunity in the previously undetermin...
SUN PHARM INDUSTRIES announced the release of Abbreviated New Drug Application (ANDA #077184) on December 16; however, details regarding the specific ...
# FDA Approves Torrent Pharmaceuticals' Generic Carbamazepine Torrent Pharmaceuticals Limited has received FDA approval for its generic carbamazepine...
Teva Pharmaceuticals USA, Inc. received FDA approval for ANDA088477 regarding the brand-name GLIPIZIDE AND METFORMIN HYDROCHLORIDE, expanding competit...
Epic Pharma LLC announced the approval of its Abbreviated New Drug Application (ANDA) for generic drug **[Substance]** on October 27, 2005. This clear...
# FDA Approves Generic Drug Application for Barr Pharmaceuticals Barr Pharmaceuticals received FDA approval for ANDA077083 on September 13, 2005, exp...
PHARMOBEDIENT announced the approval of NDA #____ (ANDA076650), scheduled generic launch on September 13, 2005. Bankers expect the approval to generat...
Following Takeda Pharmaceuticals’ expansion into the thyroid disease market, the company was granted FDA approval on August 29, 2005, for Actoplus Met...
Actavis Elizabeth has been granted FDA approval for a new generic drug, marking the company's continued entry into the generic pharmaceutical market. ...
Oceanside Pharmaceuticals announced the FDA approval of oral Metformin Hydrochloride (NDA021748), a market expansion that offers a potential cost-effe...
Viona Pharmaceuticals Inc. has secured an approval for its DMF waiver on the generic label for metformin hydrochloride, opening the door to significan...